WCA
INSP icon

Whetstone Capital Advisors’s Inspire Medical Systems INSP Stock Holding History

Whetstone Capital Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,453
Closed -$2.74M – 42
2024
Q2 		$2.74M Sell
20,453
-73
-0.4% -$13.8K 1.27% 22
2024
Q1 		$4.41M Buy
20,526
+17
+0.1% +$3.33K 1.93% 17
2023
Q4 		$4.17M Buy
+20,509
New +$3.32M 2.1% 19

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Whetstone Capital Advisors's INSP Position: Q3 2024 in Review

Whetstone Capital Advisors sold out of Inspire Medical Systems (INSP) in Q3 2024, closing a stake of 20,453 shares — an estimated $2.74M sold.

Whetstone Capital Advisors first reported a position in INSP in Q4 2023 and held it in 3 quarters. The position peaked at $4.41M in Q1 2024. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

  • Whetstone Capital Advisors reported no remaining Inspire Medical Systems position as of Q3 2024 after selling out during the quarter.
  • Whetstone Capital Advisors sold 20,453 Inspire Medical Systems shares in Q3 2024, an estimated $2.74M.
  • Whetstone Capital Advisors first reported a position in Inspire Medical Systems in Q4 2023 and held it in 3 quarters.
  • Whetstone Capital Advisors's Inspire Medical Systems position peaked at $4.41M in Q1 2024.
  • 346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on Whetstone Capital Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.